WHMIS (Acrylamide)

Workplace Hazardous Materials Information System

WHMIS 2015 classification - Note to reader

• Combustible dusts - See comments below1 2 3 4

• Acute toxicity - oral - Category 31 5 6 7 8

• Acute toxicity - dermal - Category 41 6 8

• Serious eye damage/eye irritation - Category 21 7 8

• Skin sensitization - Category 18 9 10 11 12

• Germ cell mutagenicity - Category 1B1 8

• Carcinogenicity - Category 1B7

• Reproductive toxicity - Category 1B1 7 8 13
• Toxic to the reproductive function

• Specific target organ toxicity - single exposure - Category 11 7 8

• Specific target organ toxicity - repeated exposure - Category 17 8

Danger

Toxic if swallowed (H301)
Harmful in contact with skin (H312)
Causes serious eye irritation (H319)
May cause allergic skin reaction (H317)
May cause genetic defects (H340)
May cause cancer (H350)
May damage fertility or the unborn child (H360)
Causes damage to organs (H370)
Causes damage to organs through prolonged or repeated exposure (H372)

Ingredient disclosure

Comments: This product could belong to the hazard class "Combustible dust", based on various factors related to the combustibility and explosiveness of its dust, including composition, shape and size of the particles.

References

• ▲1.  Bonnard N. et al., «Fiche toxicologique n° 119 : Acrylamide.» In: Base de données fiches toxicologiques. Paris : Institut national de recherche et de sécurité. (2007). [RE-005509]   http://www.inrs.fr/publications/bdd/fichetox.html
  http://www.inrs.fr/publications/bdd/fichetox/fiche.html?refINRS=FICHETOX_119
• ▲2.  IFA-Gestis, Information system on hazardous substances of the German Social Accident Insurance. Sankt Augustin, Germany : Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung (IFA).   https://www.dguv.de/ifa/gestis/gestis-stoffdatenbank/index-2.jsp
• ▲3.  Pohanish, R.P. et Greene, S.A., Wiley guide to chemical incompatibilities. 3ème éd. New Jersey : John Wiley & Sons Inc. (2009). [RR-015033]   www.wiley.com
• ▲4.  Pohanish, R.P. et Greene, S.A., Hazardous materials handbook. New York (NY) : Van Nostrand Reinhold. (1996). [RR-515125]
• ▲5.  American Conference of Governmental Industrial Hygienists, Documentation of the threshold limit values and biological exposure indices / Documentation of TLV's and BEI's. 7th ed. Cincinnati, Ohio : ACGIH. (2001-). Publication #0100Doc. [RM-514008]   http://www.acgih.org
• ▲6.  National Institute for Occupational Safety and Health, RTECS (Registry of Toxic Effects of Chemical Substances). Hamilton (Ont) : Canadian Centre for Occupational Health and Safety.   http://ccinfoweb.ccohs.ca/rtecs/search.html
• ▲7.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html
• ▲8.  Bureau européen des substances chimiques, European Union Risk Assessment Report : Acrylamide. 1st Priority List, Vol. 24. Luxembourg : Office for Official Publications of the European Communities. (2002). EUR 19832 EN.   http://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/acrylamidereport011.pdf
• ▲9.  Lambert, J., Matthieu, L. et Dockx, P., «Contact dermatitis from acrylamide.» Contact Dermatitis. Vol. 19, no. 1, p. 65. (1988).
• ▲10.  Dooms-Goossens, A., Garmyn, M. et Degreff, H., «Contact allergy to acrylamide.» Contact Dermatitis. Vol. 24, p. 71-72. (1991).
• ▲11.  Aalto-Korte, K. et al., «Biochemist's occupational allergic contact dermatitis from iodoacetamide and acrylamide.» Contact Dermatitis. Vol. 47, p. 361-364. (2002).
• ▲12.  Beyer, D.J. et Belsito, D.V., «Allergic contact dermatitis from acrylamide in a chemical mixer.» Contact Dermatitis. Vol. 42, no. 3, p. 181-182. (2000).
• ▲13.  Agency for Toxic Substances and Disease Registry, Toxicological profile for acrylamide. Atlanta, GA : ATSDR. (2009). Draft for public comment (update).   http://www.atsdr.cdc.gov/ToxProfiles/tp203.pdf
  http://www.atsdr.cdc.gov/

The [number] refers to the Information SST database of the CNESST Documentation Center.